type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 12/22/2025 | 12/23/2025 | 0.71469000 |
| Dividends | 12/17/2024 | 12/18/2024 | 0.18400000 |
| Dividends | 12/19/2023 | 12/20/2023 | 0.11284000 |
| Dividends | 12/29/2022 | 12/30/2022 | 0.01040000 |
| Dividends | 12/30/2021 | 12/31/2021 | 4.05354000 |
| Dividends | 12/30/2020 | 12/31/2020 | 0.000110 |
| Dividends | 12/30/2019 | 12/31/2019 | 0.05730000 |
| Dividends | 12/27/2018 | 12/28/2018 | 0.03661000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
|
Innovent Biologics Inc
|
1801 | Stock | Healthcare | US$ 178.57 B | 9,39% |
WuXi Biologics
|
2269 | Stock | Healthcare | US$ 202.28 B | 7,29% |
WuXi AppTec Co Ltd
|
603259 | Stock | Healthcare | US$ 462.19 B | 5,46% |
Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A
|
300760 | Stock | Healthcare | US$ 205.90 B | 4,63% |
Sino Biopharmaceutical Ltd
|
1177 | Stock | Healthcare | US$ 98.63 B | 3,79% |
|
Jiangsu Hengrui Medicine Co Ltd
|
600276 | Stock | Healthcare | US$ 305.44 B | 3,63% |
CSPC Pharmaceutical Group Ltd
|
1093 | Stock | Healthcare | US$ 110.46 B | 3,59% |
|
Akeso Inc
|
9926 | Stock | Healthcare | US$ 93.22 B | 3,54% |
WuXi AppTec Co Ltd H
|
2359 | Stock | Healthcare | US$ 574.17 B | 3,17% |
|
Hansoh Pharmaceutical Group Co Ltd
|
3692 | Stock | Healthcare | US$ 219.72 B | 3,10% |
Genscript Biotech Corp
|
1548 | Stock | Healthcare | US$ 69.15 B | 2,87% |
Yunnan Baiyao Group Co Ltd
|
000538 | Stock | Healthcare | US$ 91.03 B | 2,22% |
|
3SBio Inc
|
1530 | Stock | Healthcare | US$ 41.06 B | 2,17% |
|
Shanghai United Imaging Healthcare Co. Ltd. A
|
688271 | Stock | Healthcare | US$ 89.49 B | 2,13% |
|
Aier Eye Hospital Group
|
300015 | Stock | Healthcare | US$ 78.02 B | 1,89% |
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
|
600436 | Stock | Healthcare | US$ 74.66 B | 1,82% |
|
Sichuan Biokin Pharmaceutical Co. Ltd. A
|
688506 | Stock | Healthcare | US$ 107.97 B | 1,64% |
|
Sichuan Kelun Pharmaceutical Co Ltd
|
002422 | Stock | Healthcare | US$ 66.69 B | 1,60% |
Pharmaron Beijing Co Ltd
|
300759 | Stock | Healthcare | US$ 75.68 B | 1,58% |
|
Sinopharm Group Co Ltd
|
1099 | Stock | Healthcare | US$ 48.96 B | 1,47% |
|
Xizang Haisco Pharmaceutical Group Co Ltd
|
002653 | Stock | Healthcare | US$ 78.94 B | 1,45% |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
|
688578 | Stock | Healthcare | US$ 49.75 B | 1,24% |
|
Huadong Medicine Co Ltd
|
000963 | Stock | Healthcare | US$ 48.00 B | 1,18% |
Shanghai Fosun Pharmaceutical Group Co Ltd
|
600196 | Stock | Healthcare | US$ 59.66 B | 1,17% |
|
Shanghai Pharmaceuticals Holding Co Ltd
|
601607 | Stock | Healthcare | US$ 61.63 B | 1,12% |
|
WuXi XDC Cayman Inc
|
2268 | Stock | Healthcare | US$ 92.19 B | 1,12% |
|
RemeGen Co. Ltd. A
|
688331 | Stock | Healthcare | US$ 70.10 B | 1,07% |
|
Xiaocaiyuan Intl Hldg Ltd
|
0999 | Stock | Consumer Cyclical | US$ 8.84 B | 1,07% |
|
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
|
000999 | Stock | Healthcare | US$ 41.44 B | 1,01% |
Shenzhen New Industries Biomedical
|
300832 | Stock | Healthcare | US$ 40.46 B | 0,97% |
|
XtalPi Holdings Limited
|
2228 | Stock | Healthcare | US$ 31.53 B | 0,90% |
|
Shenzhen Salubris Pharmaceuticals Co Ltd
|
002294 | Stock | Healthcare | US$ 35.03 B | 0,88% |
|
CSPC Innovation Pharmaceutical Co Ltd Class A
|
300765 | Stock | Services | US$ 61.63 B | 0,87% |
|
APT Medical Inc
|
688617 | Stock | Healthcare | US$ 35.58 B | 0,86% |
| LEGN | Stock | Healthcare | US$ 4.23 B | 0,83% | |
|
Beijing Tongrentang Co Ltd
|
600085 | Stock | Healthcare | US$ 33.11 B | 0,81% |
|
Chongqing Zhifei Bio Products
|
300122 | Stock | Healthcare | US$ 31.72 B | 0,81% |
|
Shanghai RAAS Blood Products Co Ltd Class A
|
002252 | Stock | Healthcare | US$ 32.44 B | 0,80% |
|
Changchun High & New Technology Industries Group Inc
|
000661 | Stock | Healthcare | US$ 30.08 B | 0,74% |
|
Imeik Technology Development Co
|
300896 | Stock | Healthcare | US$ 28.29 B | 0,70% |
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
|
603392 | Stock | Healthcare | US$ 34.99 B | 0,65% |
|
Hebei Changshan Biochem Pharma
|
300255 | Stock | Healthcare | US$ 21.31 B | 0,54% |
Hangzhou Tigermed Consulting
|
300347 | Stock | Healthcare | US$ 43.05 B | 0,48% |
Average Investor10 user rating
4.0
(0 people)
KraneShares MSCI All China Health Care Index ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $107.78 million.
Over the past 12 months, KraneShares MSCI All China Health Care Index ETF recorded a return of -7.74%, with its price trading between $14.52 and $21.45 during the same period.
The ETF is traded under the ticker KURE.
The current price of KURE is $18.30. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
KURE is currently trading at $18.30, with a market capitalization of approximately $107.783.690,00. Over the past year, the ETF has delivered a -7.74% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in KURE through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol KURE, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, KURE has returned -4.14%, and -7.74% over the past year.
If you were to purchase 100 shares of KURE at the current price of $18.30, your total investment would be $1,830.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
